Impact of Low Muscle Mass on Hepatocellular Carcinoma Patients Undergoing Transcatheter Liver-Directed Therapies: Systematic Review & Meta-Analysis.
Yen-Chun ChenMeng-Hsuan KuoChing-Sheng HsuI-Ting KaoChen-Yi WuChih-Wei TsengShih-Chieh ShaoPublished in: Cancers (2024)
In intermediate-stage HCC, LSMM is common and associated with reduced OS. To achieve an optimal prognosis, clinicians should incorporate routine LSMM measurement into practice, while caring for patients with intermediate-stage HCC, irrespective of TACE, TAE, and TARE.